Company intelligence / Profile preview

zzzzztp

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

ZZ Biotech is a Houston-based clinical-stage biopharmaceutical company developing biologic therapies for major unmet needs in neurology and wound care. Its lead candidate, the genetically engineered protein drug '3K3A-APC', has completed a successful NIH-funded Phase II trial for acute ischemic stroke (RHAPSODY), showing safety and moving toward a pivotal multinational Phase III trial funded by an NIH grant (~$30M). The FDA granted Fast Track designation to this program. Additional studies are underway or planned for ALS and chronic wound indications[1][2][3].

Therapeutic areas: DermatologyCardiovascularEndocrinologyNeurology
Modalities: BiologicProtein
Industry: Biotech

Partnerships

National Institutes of Health/NINDSKeck School of Medicine of USC

Beyond the preview

Go deeper on zzzzztp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zzzzztp.

Explore the full profile